CytoMed Therapeutics (GDTC) Earnings Date & Reports

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GDTC is expected to report earnings to -3 cents per share on May 05

CytoMed Therapeutics GDTC Stock Earnings Reports

Q4'24

Est.

$-0.04

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

Q4'23

Est.

$-0.05

The last earnings report on November 27 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 7.30K shares outstanding, the current market capitalization sits at 25.76M.

View a ticker or compare two or three

Compare

GDTC